Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INBX | ATAI | GLUE | ||
| Company | Inhibrx Biosciences Inc | Ataibeckley Inc | Monte Rosa Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 118.41 | 4.80 | 20.87 | ||
| High | 131.00 | 4.89 | 21.23 | ||
| Low | 116.07 | 4.60 | 20.26 | ||
| Latest | 125.25 | 4.84 | 20.47 | ||
| Change | +10.16 | +0.13 | -0.51 | ||
| % Change | +8.83% | +2.76% | -2.43% | ||
| Volume | 468,910 | 5,380,189 | 271,362 | ||
| 20-Day Average Volume | 404,983 | 6,895,069 | 1,021,609 | ||
| Previous Close | 115.09 | 4.71 | 20.98 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 77.53 | 3.96 | 17.89 | ||
| 20-Day Raw Stochastic | 71.53% | 68.34% | 81.57% | ||
| 20-Day Relative Strength | 77.55 | 66.37 | 63.55 | ||
| Weighted Alpha | +382.58 | +157.47 | +156.70 | ||
| Today's Opinion | 88% Buy | 24% Buy | 72% Buy | ||
| Previous Opinion | 72% Buy | 16% Buy | 72% Buy | ||
| Last Month's Opinion | 8% Sell | 100% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +53.28% since 04/16/26 | +17.73% since 04/16/26 | +9.36% since 04/16/26 | ||
| Low | 80.83 on 04/20/26 | 4.00 on 04/17/26 | 18.75 on 04/17/26 | ||
| High | 155.29 on 04/22/26 | 5.51 on 04/20/26 | 21.62 on 04/22/26 | ||
| 1-Month | |||||
| %Chg | +97.11% since 03/23/26 | +42.04% since 03/23/26 | +36.06% since 03/23/26 | ||
| Low | 57.30 on 03/27/26 | 3.27 on 03/24/26 | 14.20 on 03/24/26 | ||
| High | 155.29 on 04/22/26 | 5.51 on 04/20/26 | 21.62 on 04/22/26 | ||
| 3-Month | |||||
| %Chg | +70.63% since 01/23/26 | +16.02% since 01/23/26 | -10.46% since 01/23/26 | ||
| Low | 57.30 on 03/27/26 | 3.27 on 03/24/26 | 14.20 on 03/24/26 | ||
| High | 155.29 on 04/22/26 | 5.51 on 04/20/26 | 23.29 on 01/27/26 | ||
| 6-Month | |||||
| %Chg | +349.19% since 10/23/25 | -13.24% since 10/23/25 | +97.01% since 10/23/25 | ||
| Low | 46.01 on 10/24/25 | 3.27 on 03/24/26 | 10.21 on 10/24/25 | ||
| High | 155.29 on 04/22/26 | 6.23 on 10/27/25 | 25.77 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,681,120 | 1,717,954 | 1,678,736 | ||
| Shares Outstanding, K | 14,607 | 364,746 | 80,016 | ||
| Annual Sales | 1,300,000 | 4,090,000 | 123,670,000 | ||
| Annual Net Income | -140,060,000 | -660,050,000 | -38,630,000 | ||
| Last Quarter Sales | 0 | 1,070,000 | 2,780,000 | ||
| Last Quarter Net Income | -35,260,000 | -544,810,000 | -46,140,000 | ||
| 60-Month Beta | 1.82 | 1.57 | 1.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.11 on 03/19/26 | -0.05 on 03/06/26 | -0.55 on 03/17/26 | ||
| Latest Earnings Date | 05/13/26 | 05/13/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 06/08/17 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||